Latest News

If you have been wondering whether Lamb Weston Holdings is a beaten down bargain or a value trap, you are not alone. This article will walk through what the numbers really say. The stock has slipped about 21.5% over the last year and is still down 9.6% year to date, even though the last week and month saw only modest moves of 0.3% and 4.4% respectively. Investors have been recalibrating expectations as the company navigates shifting consumer demand for frozen potato products and ongoing cost...

In recent months, Louisiana-Pacific Corporation has drawn heightened attention as analysts sharply revised down near-term earnings forecasts, with Zacks assigning the stock its weakest Rank #5 rating based on these estimate cuts. This shift in analyst expectations underscores how quickly sentiment around Louisiana-Pacific’s earnings power can change, even as its longer-term business themes remain in focus. Next, we’ll examine how this downgrade in earnings expectations and Zacks Rank #5...

Papa John's International (PZZA) just handed 85 Washington, D.C. and Baltimore locations to franchise powerhouse Pie Investments and paired that move with plans for 52 new stores by 2030, reshaping its Mid Atlantic footprint. See our latest analysis for Papa John's International. Even with this sizable refranchising and a 52 store growth pipeline, Papa John's 90 day share price return of minus 15.6 percent and one year total shareholder return of minus 14.4 percent suggest sentiment is still...

Key Insights Significantly high institutional ownership implies ICICI Bank's stock price is sensitive to their trading...

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

DN Automotive Corporation's ( KRX:007340 ) price-to-earnings (or "P/E") ratio of 5.8x might make it look like a strong...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Earlier this month, Getty Realty Corp. entered into a Note Purchase Agreement for US$250 million of senior unsecured notes to repay revolving credit facility borrowings and fund general corporate purposes. By locking in this unsecured funding, Getty Realty is reshaping its debt mix in a way that could influence its investment capacity and risk profile. We'll now examine how this new US$250 million unsecured financing affects Getty Realty's investment narrative, particularly its balance sheet...

JD Logistics (SEHK:2618) has quietly inched higher this week, and that steady move is catching investors’ attention. With shares still down over the past year, the focus is shifting to whether fundamentals now justify a fresh look. See our latest analysis for JD Logistics. The modest climb in the 7 day share price return, against a still weak 1 year total shareholder return, suggests sentiment may be stabilising as investors reassess JD Logistics’ growth and margin prospects at around...

Vishay Intertechnology recently introduced two 1200 V silicon carbide MOSFET power modules in low-profile MAACPAK PressFit packages and a 1500 V Automotive Grade solid-state relay for 800 V battery monitoring, targeting automotive, energy, industrial, and telecom applications with higher efficiency, reliability, and compliance with key isolation standards. Together, these launches highlight Vishay’s push into higher-voltage, silicon carbide-based and safety-critical products that can deepen...

In recent months, iRhythm Technologies has faced heightened scrutiny, including an FDA warning letter, a DOJ investigation, and a new shareholder rights law firm probe into potential fiduciary breaches by officers and directors. These overlapping regulatory and legal pressures contrast with iRhythm's ongoing innovation in its Zio cardiac monitoring platform, creating a complex backdrop for assessing its business quality and governance. We’ll now explore how this added regulatory and legal...

Ventas Realty, a subsidiary of Ventas, Inc., recently issued and sold US$500,000,000 of 5.000% Senior Notes due 2036, with proceeds earmarked for general corporate purposes including potential debt repayment and boosting financial flexibility. This debt raise, alongside upbeat analyst commentary on Ventas’ healthcare real estate platform, underscores investor focus on the REIT’s balance sheet strength and capacity to fund growth. We’ll now explore how Ventas’ recent senior notes issuance...

With its stock down 11% over the past month, it is easy to disregard FLSmidth (CPH:FLS). However, stock prices are...

AltaGas Ltd.’s board has approved a 6% increase to the annual common share dividend to CA$1.34 per share for 2026, with the first quarterly payment of CA$0.334 per share scheduled for March 31, 2026, to shareholders of record on March 16, 2026. Alongside this dividend uplift, AltaGas has kept Ridley Island Propane Export Terminal exports running through a labour strike by activating contingency plans and signaling minimal expected financial impact, underlining the resilience of its utility...

FireFly Metals (ASX:FFM) has jumped onto investors radar after launching a series of discounted equity raisings worth about A$139 million, all aimed squarely at accelerating its Green Bay copper gold project in Canada. See our latest analysis for FireFly Metals. Despite a modest pullback in the last week, FireFly’s share price has climbed sharply in recent months, with a 90 day share price return of 50% and a one year total shareholder return of 73.91%, suggesting momentum is building as the...

Revolve Group (RVLV) just delivered an upside earnings surprise while a key insider and major shareholder cashed out roughly 178,700 shares, about 4.7 million dollars. This combination naturally has investors double checking the story. See our latest analysis for Revolve Group. The upbeat earnings surprise, combined with insider selling, has come as the share price sits around 25.97 dollars, with a 1 month share price return of about 21 percent but a 1 year total shareholder return still...

There wouldn't be many who think Almirall, S.A.'s ( BME:ALM ) price-to-sales (or "P/S") ratio of 2.6x is worth a...

As the FTSE 100 and FTSE 250 indices face downward pressure due to weak trade data from China, investors in the United Kingdom are keenly observing how global economic challenges impact domestic markets. In such a climate, identifying stocks trading below their estimated value can present opportunities for those looking to navigate these uncertain times with strategic investments.

The UK stock market has recently experienced fluctuations, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns over global economic recovery. Despite these challenges, investors often find opportunities in lesser-known areas of the market. Penny stocks, although an outdated term, still represent smaller or newer companies that can offer significant value and potential growth for those willing to explore beyond the mainstream indices.

As the United Kingdom's FTSE 100 index experiences turbulence due to weak trade data from China, investors are keenly observing how these global economic shifts impact their portfolios. In such uncertain times, dividend stocks can offer a measure of stability and income, making them an attractive option for those looking to navigate the current market volatility.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

If you are wondering whether Vertex Pharmaceuticals at around $455 a share is still a smart buy or if the best days are already priced in, you are not alone. The stock has climbed 7.0% over the last week and 11.2% over the past month. It is still only up 12.3% year to date and is actually down 3.9% over the last year, despite a strong 45.0% three year and 99.7% five year run. Recent headlines have focused on Vertex's expanding pipeline in cystic fibrosis and non opioid pain, along with...